LN229 SMAD/TGFbeta Reporter (Luc) stable cell line
LN229 SMAD/TGFbeta Reporter (Luc) cells are derived from the human glioblastoma cell line LN229 by stably integration of a SMAD/TGFbeta firefly luciferase reporter construct. The LN229 cell line has been widely used in studies to understand the biology of glioblastoma and to test potential treatments. LN229 SMAD/TGFbeta Reporter (Luc) cells stably express firefly luciferase under the control of the SMAD/TGFbeta response elements, can be used for monitoring the activity of TGF?/SMAD signaling pathway.
Product Specifications
No additional specifications available.
More Discoveries
Explore Other Products
Browse additional items from our catalog
L3189-90A-HRP 100 µL
LMO2 (LIM Domain Only Protein 2, Rhombotin-2, LMO-2, Cysteine-rich Protein TTG-2, RBTN2, RBTNL1, RHOM2, T-cell Translocation Protein 2, TTG2) (HRP) discontinued
Sign In for Pricing
View Details